Nadav Kidron insider trades

Open-market stock purchases and sales by Nadav Kidron, President and CEO at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since Apr 21, 2010.

Recent trades

DateStockTradeValue
Mar 30, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$148K
Mar 25, 2026LFWD Lifeward LtdBought (not open market)—
Mar 17, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Mar 12, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)—
Jan 22, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—

Companies traded

  • ORMP Oramed Pharmaceuticals Inc: 11 buys, 3 sales, last Mar 30, 2026
  • LFWD Lifeward Ltd: other filings, last Mar 25, 2026
  • ORMP.OB Oramed Pharmaceuticals Inc: other filings, last Aug 8, 2012

Get free alerts when Nadav Kidron files a new trade →